NCAM signaling for neurite out-growth

No Pathway Network information available for NCAM signaling for neurite out-growth

Pathways in the NCAM signaling for neurite out-growth SuperPath

#	Name	Source	Genes
1	NCAM signaling for neurite out-growth	Reactome	AGRN ARTN CACNA1C CACNA1D CACNA1G CACNA1H CACNA1I CACNA1S CACNB1 CACNB2 CACNB3 CACNB4 CNTN2 COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A1 COL6A2 COL6A3 COL6A5 COL6A6 COL9A1 COL9A2 COL9A3 CREB1 FGFR1 FYN GDNF GFRA1 GFRA2 GFRA4 GRB2 HRAS KRAS MAPK1 MAPK3 NCAM1 NCAN NRAS NRTN PRNP PSPN PTK2 PTPRA RPS6KA5 SOS1 SPTA1 SPTAN1 SPTB SPTBN1 SPTBN2 SPTBN4 SPTBN5 SRC ST8SIA2 ST8SIA4 (see all 63) (see less)
2	NCAM1 interactions	Reactome	AGRN ARTN CACNA1C CACNA1D CACNA1G CACNA1H CACNA1I CACNA1S CACNB1 CACNB2 CACNB3 CACNB4 CNTN2 COL2A1 COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL5A3 COL6A1 COL6A2 COL6A3 COL6A5 COL6A6 COL9A1 COL9A2 COL9A3 GDNF GFRA1 GFRA2 GFRA4 NCAM1 NCAN NRTN PRNP PSPN ST8SIA2 ST8SIA4 (see all 42) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	COL2A1	Collagen Type II Alpha 1 Chain	Protein Coding	2
2	COL3A1	Collagen Type III Alpha 1 Chain	Protein Coding	2
3	COL4A1	Collagen Type IV Alpha 1 Chain	Protein Coding	2
4	COL4A2	Collagen Type IV Alpha 2 Chain	Protein Coding	2
5	COL4A3	Collagen Type IV Alpha 3 Chain	Protein Coding	2
6	COL4A4	Collagen Type IV Alpha 4 Chain	Protein Coding	2
7	COL4A5	Collagen Type IV Alpha 5 Chain	Protein Coding	2
8	COL5A1	Collagen Type V Alpha 1 Chain	Protein Coding	2
9	COL5A2	Collagen Type V Alpha 2 Chain	Protein Coding	2
10	COL6A1	Collagen Type VI Alpha 1 Chain	Protein Coding	2
11	COL6A2	Collagen Type VI Alpha 2 Chain	Protein Coding	2
12	COL6A3	Collagen Type VI Alpha 3 Chain	Protein Coding	2
13	COL9A1	Collagen Type IX Alpha 1 Chain	Protein Coding	2
14	COL9A2	Collagen Type IX Alpha 2 Chain	Protein Coding	2
15	COL9A3	Collagen Type IX Alpha 3 Chain	Protein Coding	2
16	COL6A6	Collagen Type VI Alpha 6 Chain	Protein Coding	2
17	NCAN	Neurocan	Protein Coding	2
18	COL6A5	Collagen Type VI Alpha 5 Chain	Protein Coding	2
19	GDNF	Glial Cell Derived Neurotrophic Factor	Protein Coding	2
20	GFRA1	GDNF Family Receptor Alpha 1	Protein Coding	2
21	GFRA2	GDNF Family Receptor Alpha 2	Protein Coding	2
22	AGRN	Agrin	Protein Coding	2
23	NCAM1	Neural Cell Adhesion Molecule 1	Protein Coding	2
24	NRTN	Neurturin	Protein Coding	2
25	COL5A3	Collagen Type V Alpha 3 Chain	Protein Coding	2
26	PRNP	Prion Protein (Kanno Blood Group)	Protein Coding	2
27	PSPN	Persephin	Protein Coding	2
28	GFRA4	GDNF Family Receptor Alpha 4	Protein Coding	2
29	CNTN2	Contactin 2	Protein Coding	2
30	CACNA1C	Calcium Voltage-Gated Channel Subunit Alpha1 C	Protein Coding	2
31	CACNA1D	Calcium Voltage-Gated Channel Subunit Alpha1 D	Protein Coding	2
32	CACNA1S	Calcium Voltage-Gated Channel Subunit Alpha1 S	Protein Coding	2
33	CACNB1	Calcium Voltage-Gated Channel Auxiliary Subunit Beta 1	Protein Coding	2
34	CACNB2	Calcium Voltage-Gated Channel Auxiliary Subunit Beta 2	Protein Coding	2
35	CACNB3	Calcium Voltage-Gated Channel Auxiliary Subunit Beta 3	Protein Coding	2
36	CACNB4	Calcium Voltage-Gated Channel Auxiliary Subunit Beta 4	Protein Coding	2
37	ST8SIA4	ST8 Alpha-N-Acetyl-Neuraminide Alpha-2,8-Sialyltransferase 4	Protein Coding	2
38	ST8SIA2	ST8 Alpha-N-Acetyl-Neuraminide Alpha-2,8-Sialyltransferase 2	Protein Coding	2
39	CACNA1I	Calcium Voltage-Gated Channel Subunit Alpha1 I	Protein Coding	2
40	CACNA1H	Calcium Voltage-Gated Channel Subunit Alpha1 H	Protein Coding	2
41	CACNA1G	Calcium Voltage-Gated Channel Subunit Alpha1 G	Protein Coding	2
42	ARTN	Artemin	Protein Coding	2
43	CREB1	CAMP Responsive Element Binding Protein 1	Protein Coding	1
44	FGFR1	Fibroblast Growth Factor Receptor 1	Protein Coding	1
45	FYN	FYN Proto-Oncogene, Src Family Tyrosine Kinase	Protein Coding	1
46	GRB2	Growth Factor Receptor Bound Protein 2	Protein Coding	1
47	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	1
48	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	1
49	NRAS	NRAS Proto-Oncogene, GTPase	Protein Coding	1
50	SPTBN5	Spectrin Beta, Non-Erythrocytic 5	Protein Coding	1
51	MAPK1	Mitogen-Activated Protein Kinase 1	Protein Coding	1
52	MAPK3	Mitogen-Activated Protein Kinase 3	Protein Coding	1
53	PTK2	Protein Tyrosine Kinase 2	Protein Coding	1
54	SPTBN4	Spectrin Beta, Non-Erythrocytic 4	Protein Coding	1
55	PTPRA	Protein Tyrosine Phosphatase Receptor Type A	Protein Coding	1
56	SOS1	SOS Ras/Rac Guanine Nucleotide Exchange Factor 1	Protein Coding	1
57	SPTA1	Spectrin Alpha, Erythrocytic 1	Protein Coding	1
58	SPTAN1	Spectrin Alpha, Non-Erythrocytic 1	Protein Coding	1
59	SPTB	Spectrin Beta, Erythrocytic	Protein Coding	1
60	SPTBN1	Spectrin Beta, Non-Erythrocytic 1	Protein Coding	1
61	SPTBN2	Spectrin Beta, Non-Erythrocytic 2	Protein Coding	1
62	SRC	SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase	Protein Coding	1
63	RPS6KA5	Ribosomal Protein S6 Kinase A5	Protein Coding	1

Disorders associated with NCAM signaling for neurite out-growth SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Stickler syndrome	Enrichment	COL2A1, COL9A1, COL9A2, COL9A3	7.78
2	Multiple epiphyseal dysplasia due to collagen 9 anomaly	Enrichment	COL9A1, COL9A2, COL9A3	7.56
3	Collagen vi-related dystrophies	Enrichment	COL6A1, COL6A2, COL6A3	7.56
4	Intermediate collagen vi-related muscular dystrophy	Enrichment	COL6A1, COL6A2, COL6A3	7.56
5	Digenic alport syndrome	Enrichment	COL4A3, COL4A4, COL4A5	7.56
6	Autosomal recessive stickler syndrome	Enrichment	COL9A1, COL9A2, COL9A3	6.96
7	Bethlem muscular dystrophy	Enrichment	COL6A1, COL6A2, COL6A3	6.96
8	Alport syndrome 3a, autosomal dominant	Enrichment	COL4A3, COL4A4, COL4A5	6.56
9	Ullrich congenital muscular dystrophy 1a	Enrichment	COL6A1, COL6A2, COL6A3	6.56
10	Autosomal dominant alport syndrome	Enrichment	COL4A3, COL4A4, COL4A5	6.56
11	Alport syndrome	Enrichment	COL4A3, COL4A4, COL4A5	6.56
12	Schimmelpenning-feuerstein-mims syndrome	Enrichment	HRAS, KRAS, NRAS	6.42
13	Noonan syndrome and noonan-related syndrome	Enrichment	HRAS, KRAS, NRAS, SOS1	6.26
14	Bethlem myopathy 1a	Enrichment	COL6A1, COL6A2, COL6A3	6.02
15	Connective tissue disease	Enrichment	COL2A1, COL5A1, COL9A1, COL9A3	5.57
16	Nevus, epidermal	Enrichment	HRAS, KRAS, NRAS	5.48
17	Noonan syndrome 3	Enrichment	HRAS, KRAS, SOS1	5.48
18	Noonan syndrome 1	Enrichment	HRAS, KRAS, NRAS, SOS1	5.46
19	Rasopathy	Enrichment	HRAS, KRAS, NRAS, SOS1	5.23
20	Kidney disease	Enrichment	COL4A3, COL4A4, COL4A5	4.91
21	Lung non-small cell carcinoma	Enrichment	HRAS, KRAS, NRAS	4.81
22	Pyropoikilocytosis, hereditary	Enrichment	SPTA1, SPTB	4.67
23	Encephalocraniocutaneous lipomatosis	Enrichment	FGFR1, KRAS	4.67
24	Ras-associated autoimmune leukoproliferative disorder	Enrichment	KRAS, NRAS	4.67
25	Ehlers-danlos syndrome	Enrichment	COL3A1, COL5A1, COL5A2	4.59
26	Protein-deficiency anemia	Enrichment	NRAS, SPTA1, SPTB	4.58
27	Hematuria, benign familial, 1	Enrichment	COL4A3, COL4A4	4.55
28	Ehlers-danlos syndrome, classic type, 2	Enrichment	COL5A1, COL5A2	4.55
29	Brain small vessel disease 1 with or without ocular anomalies	Enrichment	COL4A1, COL4A2	4.25
30	Alport syndrome 2, autosomal recessive	Enrichment	COL4A3, COL4A4	4.25
31	Autosomal recessive alport syndrome	Enrichment	COL4A3, COL4A4	4.25
32	Large congenital melanocytic nevus	Enrichment	HRAS, NRAS	4.20
33	Retinal detachment	Enrichment	COL2A1, COL9A3	4.03
34	Familial porencephaly	Enrichment	COL4A1, COL4A2	4.03
35	Chronic myelogenous leukemia, bcr-abl1 positive	Enrichment	KRAS, NRAS	3.90
36	Hereditary elliptocytosis	Enrichment	SPTA1, SPTB	3.90
37	Ehlers-danlos syndrome, classic type, 1	Enrichment	COL5A1, COL5A2	3.86
38	Hemorrhage, intracerebral	Enrichment	COL4A1, COL4A2	3.86
39	Keratoconus	Enrichment	COL4A1, COL5A2	3.86
40	Classic ehlers-danlos syndrome	Enrichment	COL5A1, COL5A2	3.86
41	Intervertebral disc disease	Enrichment	COL9A2, COL9A3	3.71
42	Cerebral palsy	Enrichment	CACNA1C, COL4A1, COL4A2	3.63
43	Myopathy	Enrichment	COL6A1, COL6A2, COL6A3	3.60
44	Nephrotic syndrome	Enrichment	COL4A3, COL4A4, COL4A5	3.51
45	Hereditary spherocytosis	Enrichment	SPTA1, SPTB	3.50
46	Differentiated thyroid carcinoma	Enrichment	HRAS, KRAS, NRAS	3.49
47	Familial thoracic aortic aneurysm and aortic dissection	Enrichment	COL3A1, COL5A1, COL5A2	3.48
48	Thyroid cancer, nonmedullary, 2	Enrichment	HRAS, NRAS	3.36
49	Leukemia, chronic myeloid	Enrichment	KRAS, NRAS	3.36
50	Pilomyxoid astrocytoma	Enrichment	FGFR1, KRAS	3.36
51	Follicular thyroid carcinoma	Enrichment	HRAS, NRAS	3.36
52	Hemolytic anemia	Enrichment	SPTA1, SPTB	3.36
53	Melanocytic nevus syndrome, congenital	Enrichment	HRAS, NRAS	3.23
54	Chronic kidney disease	Enrichment	COL4A4, COL4A5	3.15
55	Myopia	Enrichment	COL2A1, COL4A4	3.02
56	Hypertension	Enrichment	COL4A4, COL4A5	2.96
57	Juvenile myelomonocytic leukemia	Enrichment	KRAS, NRAS	2.87
58	Focal segmental glomerulosclerosis	Enrichment	COL4A4, COL4A5	2.77
59	Spastic ataxia	Enrichment	CACNA1G, CACNB4, SPTAN1	2.72
60	Brugada syndrome	Enrichment	CACNA1C, CACNB2	2.54
61	Heart, malformation of	Enrichment	COL2A1, MAPK1	2.51
62	Stickler syndrome, type i	Enrichment	COL2A1	2.51
63	Epiphyseal dysplasia, multiple, with myopia and conductive deafness	Enrichment	COL2A1	2.51
64	Thyrotoxic periodic paralysis 1	Enrichment	CACNA1S	2.51
65	Spondylometaphyseal dysplasia, algerian type	Enrichment	COL2A1	2.51
66	Alport syndrome 1, x-linked	Enrichment	COL4A5	2.51
67	Fatal familial insomnia	Enrichment	PRNP	2.51
68	Osteoarthritis with mild chondrodysplasia	Enrichment	COL2A1	2.51
69	Avascular necrosis of femoral head, primary, 1	Enrichment	COL2A1	2.51
70	Czech dysplasia	Enrichment	COL2A1	2.51
71	Epilepsy, idiopathic generalized 9	Enrichment	CACNB4	2.51
72	Brugada syndrome 4	Enrichment	CACNB2	2.51
73	Kniest dysplasia	Enrichment	COL2A1	2.51
74	Platyspondylic lethal skeletal dysplasia, torrance type	Enrichment	COL2A1	2.51
75	Gerstmann-straussler disease	Enrichment	PRNP	2.51
76	Spondyloepiphyseal dysplasia, stanescu type	Enrichment	COL2A1	2.51
77	Kuru	Enrichment	PRNP	2.51
78	Episodic ataxia, type 5	Enrichment	CACNB4	2.51
79	Acrogeria, gottron type	Enrichment	COL3A1	2.51
80	Epiphyseal dysplasia, multiple, 6	Enrichment	COL9A1	2.51
81	Achondrogenesis, type ii	Enrichment	COL2A1	2.51
82	Neurodevelopmental disorder with speech impairment and with or without seizures	Enrichment	CACNA1I	2.51
83	Epiphyseal dysplasia, multiple, 2	Enrichment	COL9A2	2.51
84	Congenital myopathy 18	Enrichment	CACNA1S	2.51
85	Ullrich congenital muscular dystrophy 1b	Enrichment	COL6A2	2.51
86	Spongiform encephalopathy with neuropsychiatric features	Enrichment	PRNP	2.51
87	Spondyloperipheral dysplasia	Enrichment	COL2A1	2.51
88	Myosclerosis, autosomal recessive	Enrichment	COL6A2	2.51
89	Porencephaly	Enrichment	COL4A1	2.51
90	Ullrich congenital muscular dystrophy 1c	Enrichment	COL6A3	2.51
91	Epiphyseal dysplasia, multiple, 3	Enrichment	COL9A3	2.51
92	Huntington disease-like 1	Enrichment	PRNP	2.51
93	Renal hypodysplasia/aplasia 4	Enrichment	GFRA1	2.51
94	Primary aldosteronism, seizures, and neurologic abnormalities	Enrichment	CACNA1D	2.51
95	Brugada syndrome 3	Enrichment	CACNA1C	2.51
96	Epilepsy, childhood absence 6	Enrichment	CACNA1H	2.51
97	Malignant hyperthermia 5	Enrichment	CACNA1S	2.51
98	Stickler syndrome, type i, nonsyndromic ocular	Enrichment	COL2A1	2.51
99	Stickler syndrome, type iv	Enrichment	COL9A1	2.51
100	Sinoatrial node dysfunction and deafness	Enrichment	CACNA1D	2.51
101	Familial alzheimer-like prion disease	Enrichment	PRNP	2.51
102	Dystonia 27	Enrichment	COL6A3	2.51
103	Hirschsprung disease 3	Enrichment	GDNF	2.51
104	Spinocerebellar ataxia 42	Enrichment	CACNA1G	2.51
105	Stickler syndrome, type v	Enrichment	COL9A2	2.51
106	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	Enrichment	CACNA1G	2.51
107	Prion disease	Enrichment	PRNP	2.51
108	Hyperaldosteronism, familial, type iv	Enrichment	CACNA1H	2.51
109	Qualitative or quantitative defects of collagen 6	Enrichment	COL6A2	2.51
110	Vitreoretinopathy with phalangeal epiphyseal dysplasia	Enrichment	COL2A1	2.51
111	Bethlem myopathy 1b	Enrichment	COL6A2	2.51
112	Col4a1-related disorders	Enrichment	COL4A1	2.51
113	Bethlem myopathy 1c	Enrichment	COL6A3	2.51
114	Retinal lattice degeneration	Enrichment	COL9A3	2.51
115	Conn's syndrome	Enrichment	CACNA1H	2.51
116	Autosomal dominant rhegmatogenous retinal detachment	Enrichment	COL2A1	2.51
117	Prp systemic amyloidosis	Enrichment	PRNP	2.51
118	Col4a1 or col4a2-related cerebral small vessel disease	Enrichment	COL4A1	2.51
119	Multiple epiphyseal dysplasia with myopia and deafness	Enrichment	COL2A1	2.51
120	Hypochondrogenesis	Enrichment	COL2A1	2.51
121	X-linked alport syndrome	Enrichment	COL4A5	2.51
122	Pneumothorax	Enrichment	COL5A1	2.51
123	Atypical timothy syndrome	Enrichment	CACNA1C	2.51
124	Aldosterone-producing adenoma with seizures and neurological abnormalities	Enrichment	CACNA1D	2.51
125	Inherited human prion disease	Enrichment	PRNP	2.51
126	Dysspondyloenchondromatosis	Enrichment	COL2A1	2.51
127	Abdominal aortic aneurysm	Enrichment	COL3A1	2.51
128	Timothy syndrome type 2	Enrichment	CACNA1C	2.51
129	Periodic paralysis with transient compartment-like syndrome	Enrichment	CACNA1S	2.51
130	Type 2 collagen-related bone disorder	Enrichment	COL2A1	2.51
131	Timothy syndrome type 1	Enrichment	CACNA1C	2.51
132	Inherited creutzfeldt-jakob disease	Enrichment	PRNP	2.51
133	Cacna1c-related disorders	Enrichment	CACNA1C	2.51
134	Hirschsprung disease 1	Enrichment	GDNF, NRTN	2.44
135	Long qt syndrome	Enrichment	CACNA1C, CACNA1S	2.39
136	Elliptocytosis 2	Enrichment	SPTA1	2.33
137	Osteoglophonic dysplasia	Enrichment	FGFR1	2.33
138	Trigonocephaly 1	Enrichment	FGFR1	2.33
139	Oculoectodermal syndrome	Enrichment	KRAS	2.33
140	Spinocerebellar ataxia 5	Enrichment	SPTBN2	2.33
141	Noonan syndrome 4	Enrichment	SOS1	2.33
142	Developmental and epileptic encephalopathy 5	Enrichment	SPTAN1	2.33
143	Melanosis, neurocutaneous	Enrichment	NRAS	2.33
144	Noonan syndrome 6	Enrichment	NRAS	2.33
145	Noonan syndrome 13	Enrichment	MAPK1	2.33
146	Spherocytosis, type 3	Enrichment	SPTA1	2.33
147	Spinocerebellar ataxia, autosomal recessive 14	Enrichment	SPTBN2	2.33
148	Developmental delay, impaired speech, and behavioral abnormalities	Enrichment	SPTBN1	2.33
149	Cardiofaciocutaneous syndrome 2	Enrichment	KRAS	2.33
150	Hyperpigmentation, familial progressive, 1	Enrichment	SPTA1	2.33
151	Hartsfield syndrome	Enrichment	FGFR1	2.33
152	Thrombocytopenia 6	Enrichment	SRC	2.33
153	Spherocytosis, type 2	Enrichment	SPTB	2.33
154	Elliptocytosis 3	Enrichment	SPTB	2.33
155	Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia	Enrichment	SPTAN1	2.33
156	Developmental delay with or without epilepsy	Enrichment	SPTAN1	2.33
157	Neuronopathy, distal hereditary motor, autosomal dominant 11	Enrichment	SPTAN1	2.33
158	Congenital pulmonary airway malformation	Enrichment	KRAS	2.33
159	Phakomatosis pigmentokeratotica	Enrichment	HRAS	2.33
160	Hartsfield-bixler-demyer syndrome	Enrichment	FGFR1	2.33
161	Neurocutaneous melanocytosis	Enrichment	NRAS	2.33
162	Ehlers-danlos syndrome, vascular type	Enrichment	COL3A1	2.21
163	Ehlers-danlos syndrome, hypermobility type	Enrichment	COL3A1	2.21
164	Spondyloepimetaphyseal dysplasia, strudwick type	Enrichment	COL2A1	2.21
165	Spondylometaphyseal dysplasia, corner fracture type	Enrichment	COL2A1	2.21
166	Otospondylomegaepiphyseal dysplasia, autosomal recessive	Enrichment	COL2A1	2.21
167	Timothy syndrome	Enrichment	CACNA1C	2.21
168	Legg-calve-perthes disease	Enrichment	COL2A1	2.21
169	Creutzfeldt-jakob disease	Enrichment	PRNP	2.21
170	Epilepsy, early-onset, 5, with or without developmental delay	Enrichment	CNTN2	2.21
171	Specific language impairment 5	Enrichment	COL4A4	2.21
172	Otospondylomegaepiphyseal dysplasia, autosomal dominant	Enrichment	COL2A1	2.21
173	Long qt syndrome 8	Enrichment	CACNA1C	2.21
174	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1	Enrichment	COL4A2	2.21
175	Stickler syndrome, type vi	Enrichment	COL9A3	2.21
176	Fibromuscular dysplasia, multifocal	Enrichment	COL5A1	2.21
177	Polymicrogyria with or without vascular-type ehlers-danlos syndrome	Enrichment	COL3A1	2.21
178	Aortic dissection	Enrichment	COL3A1	2.21
179	Glomerulonephritis	Enrichment	COL4A4	2.21
180	Familial avascular necrosis of the femoral head	Enrichment	COL2A1	2.21
181	Congenital disorder of glycosylation, type iw, autosomal dominant	Enrichment	CACNA1D	2.21
182	X-linked diffuse leiomyomatosis-alport syndrome	Enrichment	COL4A5	2.21
183	Bladder cancer	Enrichment	HRAS, KRAS	2.10
184	Non-immune hydrops fetalis	Enrichment	HRAS, KRAS	2.04
185	Mccune-albright syndrome	Enrichment	COL2A1	2.03
186	Retinal arteries, tortuosity of	Enrichment	COL4A1	2.03
187	Spondyloepiphyseal dysplasia congenita	Enrichment	COL2A1	2.03
188	Telecanthus	Enrichment	COL5A2	2.03
189	Brain small vessel disease 2	Enrichment	COL4A2	2.03
190	Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	Enrichment	COL4A1	2.03
191	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures	Enrichment	CACNA1C	2.03
192	Pilarowski-bjornsson syndrome	Enrichment	COL4A3	2.03
193	Alport syndrome 3b, autosomal recessive	Enrichment	COL4A3	2.03
194	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	Enrichment	COL4A1	2.03
195	Hematuria, benign familial, 2	Enrichment	COL4A3	2.03
196	Thyrotoxic periodic paralysis	Enrichment	CACNA1S	2.03
197	Multiple epiphyseal dysplasia	Enrichment	COL2A1	2.03
198	Fibromatosis, gingival, 1	Enrichment	SOS1	2.03
199	Costello syndrome	Enrichment	HRAS	2.03
200	Intellectual developmental disorder, x-linked, syndromic, raymond type	Enrichment	SPTAN1	2.03
201	Pulmonic stenosis	Enrichment	SOS1	2.03
202	Histiocytoma, angiomatoid fibrous	Enrichment	CREB1	2.03
203	Pfeiffer syndrome	Enrichment	FGFR1	2.03
204	Jackson-weiss syndrome	Enrichment	FGFR1	2.03
205	Chudley-mccullough syndrome	Enrichment	SPTB	2.03
206	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	Enrichment	SPTBN4	2.03
207	Dystonia 30	Enrichment	PTPRA	2.03
208	Rosette-forming glioneuronal tumor	Enrichment	FGFR1	2.03
209	Congenital hemolytic anemia	Enrichment	SPTA1	2.03
210	Interfrontal craniofaciosynostosis	Enrichment	FGFR1	2.03
211	Wooly hair nevus	Enrichment	HRAS	2.03
212	Schizencephaly	Enrichment	COL4A1	1.91
213	Ventricular fibrillation, paroxysmal familial, 1	Enrichment	CACNA1C	1.91
214	Frontotemporal dementia 2	Enrichment	PRNP	1.91
215	Malignant hyperthermia	Enrichment	CACNA1S	1.91
216	Hypogonadotropic hypogonadism 2 with or without anosmia	Enrichment	FGFR1	1.86
217	Nuchal bleb, familial	Enrichment	SOS1	1.86
218	Langerhans cell histiocytosis	Enrichment	NRAS	1.86
219	Chromosome 8p11 myeloproliferative syndrome	Enrichment	FGFR1	1.86
220	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy	Enrichment	SPTBN1	1.86
221	Short-rib thoracic dysplasia 11 with or without polydactyly	Enrichment	SPTAN1	1.86
222	Spermatocytoma	Enrichment	HRAS	1.86
223	Melanoma of soft tissue	Enrichment	CREB1	1.86
224	Leukemia, acute myeloid	Enrichment	KRAS, NRAS	1.83
225	Myasthenic syndrome, congenital, 8	Enrichment	AGRN	1.81
226	Heart conduction disease	Enrichment	CACNA1C	1.81
227	Familial cerebral saccular aneurysm	Enrichment	COL3A1	1.81
228	Developmental dysplasia of the hip 1	Enrichment	COL2A1	1.73
229	Hypokalemic periodic paralysis, type 1	Enrichment	CACNA1S	1.73
230	Anterior segment dysgenesis 5	Enrichment	COL4A1	1.73
231	Familial adult myoclonic epilepsy	Enrichment	CNTN2	1.73
232	Inguinal hernia	Enrichment	COL5A1	1.73
233	Pain disorder	Enrichment	COL5A1	1.73
234	Childhood absence epilepsy	Enrichment	CACNA1H	1.73
235	Cardiofaciocutaneous syndrome 1	Enrichment	KRAS	1.73
236	Diffuse gastric and lobular breast cancer syndrome	Enrichment	KRAS	1.73
237	Chromosome 22q11.2 deletion syndrome, distal	Enrichment	MAPK1	1.73
238	Cardiofaciocutaneous syndrome	Enrichment	KRAS	1.73
239	Lung sarcomatoid carcinoma	Enrichment	KRAS	1.73
240	Pilocytic astrocytoma	Enrichment	KRAS	1.73
241	Epidermolytic nevus	Enrichment	HRAS	1.73
242	Charcot-marie-tooth hereditary neuropathy	Enrichment	SPTAN1	1.73
243	Gingival fibromatosis	Enrichment	SOS1	1.73
244	Complex neurodevelopmental disorder	Enrichment	CACNA1C, CNTN2, SPTBN1	1.70
245	Multiple enchondromatosis, maffucci type	Enrichment	COL2A1	1.67
246	Pervasive developmental disorder	Enrichment	SPTBN1	1.64
247	Holoprosencephaly	Enrichment	FGFR1	1.64
248	Primary hypereosinophilic syndrome	Enrichment	FGFR1	1.64
249	Rare pervasive developmental disorder	Enrichment	SPTBN1	1.64
250	Gastroesophageal reflux	Enrichment	COL5A1	1.61
251	Spastic paraplegia 4, autosomal dominant	Enrichment	COL3A1	1.61
252	Orthostatic intolerance	Enrichment	COL5A1	1.61
253	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	Enrichment	CACNA1C	1.56
254	Congenital central hypoventilation syndrome	Enrichment	GDNF	1.56
255	Primary hyperaldosteronism	Enrichment	CACNA1H	1.56
256	Familial thoracic aortic aneurysm and dissection	Enrichment	COL3A1	1.56
257	Renal agenesis, bilateral	Enrichment	GFRA1	1.56
258	Holoprosencephaly 1	Enrichment	FGFR1	1.56
259	Breast adenocarcinoma	Enrichment	KRAS	1.56
260	Lung squamous cell carcinoma	Enrichment	KRAS	1.56
261	Marfan syndrome	Enrichment	COL2A1	1.52
262	Peters-plus syndrome	Enrichment	COL4A1	1.52
263	Myelofibrosis	Enrichment	SRC	1.49
264	Capillary malformation-arteriovenous malformation 1	Enrichment	KRAS	1.49
265	Gallbladder cancer	Enrichment	KRAS	1.49
266	Focal epilepsy	Enrichment	SPTAN1	1.49
267	Epilepsy, myoclonic juvenile	Enrichment	CACNB4	1.47
268	Epilepsy, idiopathic generalized	Enrichment	CACNA1H	1.47
269	Presynaptic congenital myasthenic syndromes	Enrichment	AGRN	1.47
270	Cardiac conduction defect	Enrichment	CACNA1C	1.44
271	Cutis laxa	Enrichment	COL5A1	1.44
272	Postsynaptic congenital myasthenic syndromes	Enrichment	AGRN	1.44
273	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	Enrichment	COL5A1	1.40
274	Clubfoot	Enrichment	COL5A1	1.40
275	Arteriovenous malformation	Enrichment	HRAS	1.39
276	Hypogonadotropic hypogonadism	Enrichment	FGFR1	1.39
277	Aortic aneurysm, familial thoracic 1	Enrichment	COL3A1	1.37
278	Walker-warburg syndrome	Enrichment	COL4A1	1.37
279	Cataract	Enrichment	COL5A1	1.37
280	Congenital myasthenic syndrome	Enrichment	AGRN	1.37
281	Isolated macular dystrophy	Enrichment	COL4A5	1.37
282	Corpus callosum, agenesis of	Enrichment	COL4A1	1.34
283	Anterior segment dysgenesis	Enrichment	COL4A1	1.34
284	Atypical hemolytic-uremic syndrome	Enrichment	COL4A5	1.34
285	Isolated corpus callosum agenesis	Enrichment	COL4A1	1.34
286	Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome	Enrichment	COL4A1	1.34
287	Myopathy, x-linked, with excessive autophagy	Enrichment	HRAS	1.34
288	Specific learning disability	Enrichment	MAPK1	1.30
289	Beckwith-wiedemann syndrome	Enrichment	COL6A1	1.27
290	Polycystic kidney disease	Enrichment	COL4A4	1.27
291	Septooptic dysplasia	Enrichment	FGFR1	1.26
292	Lip and oral cavity carcinoma	Enrichment	HRAS	1.26
293	Congenital myopathy	Enrichment	CACNA1S	1.24
294	Aortic valve disease 1	Enrichment	SOS1	1.23
295	Colorectal cancer	Enrichment	NRAS, SRC	1.21
296	Centronuclear myopathy	Enrichment	CACNA1S	1.20
297	Hypogonadotropic hypogonadism 7 with or without anosmia	Enrichment	FGFR1	1.20
298	Osteoporosis	Enrichment	SRC	1.20
299	Lung cancer susceptibility 3	Enrichment	KRAS	1.20
300	46,xy partial gonadal dysgenesis	Enrichment	SOS1	1.20
301	Lynch syndrome	Enrichment	KRAS	1.17
302	Cardiomyopathy, familial hypertrophic, 1	Enrichment	CACNA1C	1.14
303	Scoliosis	Enrichment	COL2A1	1.14
304	Muscular dystrophy	Enrichment	COL6A2	1.14
305	Rhabdomyosarcoma	Enrichment	HRAS	1.14
306	Gliosarcoma	Enrichment	FGFR1	1.14
307	Microform holoprosencephaly	Enrichment	FGFR1	1.14
308	Lobar holoprosencephaly	Enrichment	FGFR1	1.14
309	Giant cell glioblastoma	Enrichment	FGFR1	1.12
310	Neuromuscular disease	Enrichment	SPTAN1	1.09
311	Semilobar holoprosencephaly	Enrichment	FGFR1	1.09
312	Normosmic congenital hypogonadotropic hypogonadism	Enrichment	FGFR1	1.09
313	Arteriovenous malformations of the brain	Enrichment	KRAS	1.07
314	Long qt syndrome 1	Enrichment	CACNA1C	1.05
315	Stargardt disease 1	Enrichment	COL2A1	1.05
316	Tooth agenesis	Enrichment	FGFR1	1.01
317	Cakut	Enrichment	COL4A1	1.00
318	Genetic steroid-resistant nephrotic syndrome	Enrichment	COL4A3	1.00
319	Kallmann syndrome	Enrichment	FGFR1	0.99
320	Pancreatic cancer	Enrichment	KRAS	0.96
321	Jeune thoracic dystrophy	Enrichment	SPTAN1	0.96
322	Microcephaly	Enrichment	COL4A1, MAPK1	0.95
323	Hydrops fetalis, nonimmune	Enrichment	HRAS	0.94
324	Asphyxiating thoracic dystrophy	Enrichment	SPTAN1	0.91
325	Sensorineural hearing loss	Enrichment	COL9A1	0.86
326	Lung cancer	Enrichment	KRAS	0.86
327	Short-rib thoracic dysplasia 1 with or without polydactyly	Enrichment	SPTAN1	0.85
328	Autosomal dominant non-syndromic intellectual disability	Enrichment	CACNA1I	0.84
329	Developmental and epileptic encephalopathy	Enrichment	SPTAN1	0.81
330	Benign epilepsy with centrotemporal spikes	Enrichment	SPTAN1	0.76
331	Hereditary spastic paraplegia	Enrichment	SPTAN1	0.75
332	Centralopathic epilepsy	Enrichment	SPTAN1	0.74
333	Gastric cancer	Enrichment	KRAS	0.74
334	West syndrome	Enrichment	SPTAN1	0.73
335	Hereditary breast carcinoma	Enrichment	KRAS	0.73
336	Thrombocytopenia	Enrichment	SRC	0.70
337	Rare genetic deafness	Enrichment	COL4A5	0.66
338	Hereditary retinal dystrophy	Enrichment	COL2A1, COL9A1	0.65
339	Fundus dystrophy	Enrichment	COL2A1, COL9A1	0.65
340	Hereditary breast ovarian cancer syndrome	Enrichment	KRAS	0.65
341	Myeloma, multiple	Enrichment	KRAS	0.64
342	Breast cancer	Enrichment	KRAS	0.53
343	Ovarian cancer	Enrichment	KRAS	0.42

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

NCAM signaling for neurite out-growth

Pathway Network for NCAM signaling for neurite out-growth

Member Pathways for NCAM signaling for neurite out-growth

Pathways in the NCAM signaling for neurite out-growth SuperPath

Associated Genes for NCAM signaling for neurite out-growth

Associated Disorders for NCAM signaling for neurite out-growth

Disorders associated with NCAM signaling for neurite out-growth SuperPath

STRING Interaction Network for NCAM signaling for neurite out-growth

Sources for NCAM signaling for neurite out-growth